Champions Oncology Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Revenue	58.42	56.94	50.16	53.87	49.11	41.04
Revenue Growth (YoY)	9.06%	13.54%	-6.90%	9.70%	19.66%	27.76%
Cost of Revenue	29.15	28.39	29.4	29.53	23.63	21.45
Gross Profit	29.28	28.56	20.75	24.34	25.48	19.59
Selling, General & Admin	18.44	16.88	18.13	17.24	15.5	12.03
Research & Development	8.38	6.83	9.54	11.55	9.37	7.2
Operating Expenses	26.82	23.71	27.68	28.79	24.87	19.23
Operating Income	2.46	4.85	-6.92	-4.45	0.61	0.37
Interest Expense	-0.03	-0.03	-0.03	-	-	-
Interest & Investment Income	0.09	0.09	0.09	-	-	-
Currency Exchange Gain (Loss)	0.01	0.01	-0.02	-0.01	-0.02	-0.01
Other Non Operating Income (Expenses)	0.14	0	-	-	-	-
EBT Excluding Unusual Items	2.67	4.92	-6.87	-4.46	0.58	0.36
Gain (Loss) on Sale of Assets	-0.31	-0.29	-0.44	-	-	-
Asset Writedown	-	-	-	-0.81	-	-
Other Unusual Items	-	-	-	-	-	0.08
Pretax Income	2.36	4.63	-7.31	-5.27	0.58	0.44
Income Tax Expense	-0.07	-0.08	-0.03	0.07	0.04	0.08
Net Income	2.49	4.7	-7.28	-5.34	0.55	0.36
Net Income to Common	2.49	4.7	-7.28	-5.34	0.55	0.36
Net Income Growth	-	-	-	-	51.38%	-
Shares Outstanding (Basic)	14	14	14	14	13	13
Shares Outstanding (Diluted)	14	14	14	14	14	15
Shares Change (YoY)	4.06%	5.31%	0.04%	-4.37%	-2.84%	23.05%
EPS (Basic)	0.18	0.34	-0.54	-0.39	0.04	0.03
EPS (Diluted)	0.17	0.33	-0.54	-0.39	0.04	0.02
EPS Growth	-	-	-	-	100.01%	-
Free Cash Flow	5.64	7	-6.97	1.1	4.11	-4.96
Free Cash Flow Per Share	0.40	0.49	-0.52	0.08	0.29	-0.34
Gross Margin	50.11%	50.15%	41.38%	45.18%	51.88%	47.74%
Operating Margin	4.22%	8.51%	-13.80%	-8.26%	1.24%	0.89%
Profit Margin	4.26%	8.25%	-14.51%	-9.90%	1.12%	0.88%
Free Cash Flow Margin	9.65%	12.29%	-13.90%	2.04%	8.38%	-12.09%
EBITDA	3.97	6.49	-5.05	-2.83	2.23	1.55
EBITDA Margin	6.79%	11.39%	-10.08%	-5.26%	4.55%	3.78%
D&A For EBITDA	1.51	1.64	1.87	1.62	1.63	1.18
EBIT	2.46	4.85	-6.92	-4.45	0.61	0.37
EBIT Margin	4.22%	8.51%	-13.80%	-8.26%	1.24%	0.89%
Effective Tax Rate	-	-	-	-	6.00%	17.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.